Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The dysbiosis signature of Fusobacterium nucleatum in colorectal cancer-cause or consequences? A systematic review
Maryam Ranjbar, Rasoul Salehi, Shaghayegh Haghjooy Javanmard, et al.
Cancer Cell International (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 60

Showing 1-25 of 60 citing articles:

Gut microbiome and its role in colorectal cancer
Martina Reberšek
BMC Cancer (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 251
The double-edged sword of probiotic supplementation on gut microbiota structure in Helicobacter pylori management
Ali Nabavi-Rad, Amir Sadeghi, Hamid Asadzadeh Aghdaei, et al.
Gut Microbes (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 75
Gut Dysbiosis and Intestinal Barrier Dysfunction: Potential Explanation for Early-Onset Colorectal Cancer
Siti Maryam Ahmad Kendong, Raja Affendi Raja Ali, Khairul Najmi Muhammad Nawawi, et al.
Frontiers in Cellular and Infection Microbiology (2021) Vol. 11
Open Access | Times Cited: 71
Implication of Obesity and Gut Microbiome Dysbiosis in the Etiology of Colorectal Cancer
Samradhi Singh, Poonam Sharma, Devojit Kumar Sarma, et al.
Cancers (2023) Vol. 15, Iss. 6, pp. 1913-1913
Open Access | Times Cited: 36
Human microbiomes in cancer development and therapy
Chenglai Xia, Jiyan Su, Can Liu, et al.
MedComm (2023) Vol. 4, Iss. 2
Open Access | Times Cited: 27
Compared to histamine-2 receptor antagonist, proton pump inhibitor induces stronger oral-to-gut microbial transmission and gut microbiome alterations: a randomised controlled trial
Jiaying Zhu, Chuqing Sun, Min Li, et al.
Gut (2023) Vol. 73, Iss. 7, pp. 1087-1097
Open Access | Times Cited: 24
The Roles and Interactions of Porphyromonas gingivalis and Fusobacterium nucleatum in Oral and Gastrointestinal Carcinogenesis: A Narrative Review
Bing Wang, Juan Deng, Valentina Donati, et al.
Pathogens (2024) Vol. 13, Iss. 1, pp. 93-93
Open Access | Times Cited: 15
Unraveling the Role of Fusobacterium nucleatum in Colorectal Cancer: Molecular Mechanisms and Pathogenic Insights
Linda Galasso, Fabrizio Termite, Irene Mignini, et al.
Cancers (2025) Vol. 17, Iss. 3, pp. 368-368
Open Access | Times Cited: 1
Microbiota-Immune Interactions in Ulcerative Colitis and Colitis Associated Cancer and Emerging Microbiota-Based Therapies
Jelena Popov, Valentina Caputi, Nandini Nandeesha, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 11365-11365
Open Access | Times Cited: 52
TLR4 signaling in the development of colitis-associated cancer and its possible interplay with microRNA-155
Jie Guo, Mengfan Liao, Jun Wang
Cell Communication and Signaling (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 45
Enterococcus faecalis promotes a migratory and invasive phenotype in colon cancer cells
Ashley J. Williamson, Rick Jacobson, Jasper B. van Praagh, et al.
Neoplasia (2022) Vol. 27, pp. 100787-100787
Open Access | Times Cited: 36
Fusobacterium nucleatum aggravates ulcerative colitis through promoting gut microbiota dysbiosis and dysmetabolism
Shulan Lin, Xiaoyue Zhang, Xuanzhi Zhu, et al.
Journal of Periodontology (2022) Vol. 94, Iss. 3, pp. 405-418
Closed Access | Times Cited: 31
Colorectal Cancer Stage-Specific Fecal Bacterial Community Fingerprinting of the Taiwanese Population and Underpinning of Potential Taxonomic Biomarkers
Chuan‐Yin Fang, Jung‐Sheng Chen, Bing‐Mu Hsu, et al.
Microorganisms (2021) Vol. 9, Iss. 8, pp. 1548-1548
Open Access | Times Cited: 33
The gut microbiota can orchestrate the signaling pathways in colorectal cancer
Astrid Louise Bjørn Bennedsen, Sara Furbo, Thomas Bjarnsholt, et al.
Apmis (2022) Vol. 130, Iss. 3, pp. 121-139
Open Access | Times Cited: 24
Exploring the role of Fusobacterium nucleatum in colorectal cancer: implications for tumor proliferation and chemoresistance
Leila Dadgar-Zankbar, Zahra Elahi, Aref Shariati, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 5
Dysbiosis of human microbiome and infectious diseases
Aeshna Gupta, Vijai Singh, Indra Mani
Progress in molecular biology and translational science (2022), pp. 33-51
Closed Access | Times Cited: 22
Salivary Fusobacterium nucleatum serves as a potential biomarker for colorectal cancer
Xin Zhang, Yaping Zhang, Xinru Gui, et al.
iScience (2022) Vol. 25, Iss. 5, pp. 104203-104203
Open Access | Times Cited: 21
The Nutrition-Microbiota-Physical Activity Triad: An Inspiring New Concept for Health and Sports Performance
Nathalie Boisseau, Nicolas Barnich, Christelle Koechlin‐Ramonatxo
Nutrients (2022) Vol. 14, Iss. 5, pp. 924-924
Open Access | Times Cited: 19
Association of Lactobacillus, Firmicutes, Bifidobacterium, Clostridium, and Enterococcus with colorectal cancer in Iranian patients
Zahra Elahi, Aref Shariati, Narjess Bostanghadiri, et al.
Heliyon (2023) Vol. 9, Iss. 12, pp. e22602-e22602
Open Access | Times Cited: 12
Is the oral pathogen, Porphyromona gingivalis, associated to colorectal cancer?: a systematic review
Antonio Navarro‐Sánchez, María Ángeles Nieto-Vitoria, José A López-López, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Probiotics in colorectal cancer prevention and therapy: mechanisms, benefits, and challenges
Djilali Seghir Morsli, Hadja Fatima Tbahriti, Fouzia Rahli, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Optimizing Cancer Treatment Through Gut Microbiome Modulation
Kyuri Kim, Mingyu Lee, Yoojin Shin, et al.
Cancers (2025) Vol. 17, Iss. 7, pp. 1252-1252
Open Access
Neoantigen-based immunotherapy: advancing precision medicine in cancer and glioblastoma treatment through discovery and innovation
Moawiah M. Naffaa, Ola A Al-Ewaidat, Sopiko Gogia, et al.
Exploration of Targeted Anti-tumor Therapy (2025) Vol. 6
Open Access
The human microbiome: redefining cancer pathogenesis and therapy
Yogita K. Adlakha, Ravindresh Chhabra
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access
Healthy microbiome – a mere idea or a sound concept?
Lucie Najmanová, Petra Vídeňská, Monika Cahová
Physiological Research (2022) Vol. 71, Iss. 6, pp. 719-738
Open Access | Times Cited: 17
Page 1 - Next Page

Scroll to top